Literature DB >> 14566704

Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.

Xiao-Ping Zhou1, Deborah J Marsh, Carl D Morrison, Abhik R Chaudhury, Marius Maxwell, Guido Reifenberger, Charis Eng.   

Abstract

Lhermitte-Duclos disease (LDD), or dysplastic gangliocytoma of the cerebellum, is an unusual hamartomatous overgrowth disorder. LDD can be familial or, more commonly, sporadic. It has been only recently recognized that LDD may be associated with Cowden syndrome (CS). Over 80% of patients with CS carry germline mutations in PTEN. It remains unclear whether all cases of LDD, even without features of CS, are caused by germline PTEN mutation and whether somatic PTEN mutation occurs in sporadic LDD. We obtained paraffin-embedded LDD lesions from 18 unselected, unrelated patients and performed mutational analysis of PTEN. Overall, 15 (83%) of 18 samples were found to carry a PTEN mutation. All individuals with mutations were adult-onset patients, but the three without mutations were diagnosed at the ages of 1, 3, and 11 years. Germline DNA was available from six adult-onset cases, and all had germline PTEN mutations. Of these six, two had CS features, one did not have CS features, and three were of unknown CS status. Immunohistochemistry revealed that 75% of the LDD samples had complete or partial loss of PTEN expression accompanied by elevated phosphorylated Akt, specifically in the dysplastic gangliocytoma cells. These data suggest that the loss of PTEN function is sufficient to cause LDD. The high frequency and spectrum of germline PTEN mutations in patients ascertaining by LDD alone confirm that LDD is an important defining feature of CS. Individuals with LDD, even without apparent CS features, should be counseled as in CS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566704      PMCID: PMC1180498          DOI: 10.1086/379382

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  46 in total

1.  Will the real Cowden syndrome please stand up: revised diagnostic criteria.

Authors:  C Eng
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

2.  Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.

Authors:  A Perren; P Komminoth; P Saremaslani; C Matter; S Feurer; J A Lees; P U Heitz; C Eng
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.

Authors:  X P Zhou; O Gimm; H Hampel; T Niemann; M J Walker; C Eng
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death.

Authors:  L P Weng; O Gimm; J B Kum; W M Smith; X P Zhou; D Wynford-Thomas; G Leone; C Eng
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

5.  PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways.

Authors:  L Weng; J Brown; C Eng
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

6.  PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.

Authors:  L P Weng; W M Smith; P L Dahia; U Ziebold; E Gil; J A Lees; C Eng
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

7.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

Authors:  G L Mutter; M C Lin; J T Fitzgerald; J B Kum; J P Baak; J A Lees; L P Weng; C Eng
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

8.  Cowden disease and Lhermitte-Duclos disease: characterization of a new phakomatosis.

Authors:  S Robinson; A R Cohen
Journal:  Neurosurgery       Date:  2000-02       Impact factor: 4.654

Review 9.  PTEN: one gene, many syndromes.

Authors:  Charis Eng
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

10.  Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.

Authors:  O Gimm; A Perren; L P Weng; D J Marsh; J J Yeh; U Ziebold; E Gil; R Hinze; L Delbridge; J A Lees; G L Mutter; B G Robinson; P Komminoth; H Dralle; C Eng
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

View more
  51 in total

Review 1.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

2.  Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.

Authors:  Kristi L Bennett; Jessica Mester; Charis Eng
Journal:  JAMA       Date:  2010-12-22       Impact factor: 56.272

3.  Lhermitte-Duclos disease.

Authors:  Sugata Narayan Biswas; Partha Pratim Chakraborty; Shinjan Patra
Journal:  BMJ Case Rep       Date:  2016-02-15

4.  Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.

Authors:  Martina Rudelius; Stefania Pittaluga; Satoshi Nishizuka; Trinh H-T Pham; Falko Fend; Elaine S Jaffe; Leticia Quintanilla-Martinez; Mark Raffeld
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

Review 5.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

Review 6.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

Review 7.  Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.

Authors:  Peter P Stanich; Robert Pilarski; Jonathan Rock; Wendy L Frankel; Samer El-Dika; Marty M Meyer
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

8.  Magnetic resonance characteristics of adult-onset Lhermitte-Duclos disease: An indicator for active cancer surveillance?

Authors:  Guangquan Wei; Wei Zhang; Qinlong Li; Xiaowei Kang; Haitao Zhao; Xianping Liu; Xing Tang; Yuanming Wu; Juntao Han; Hong Yin
Journal:  Mol Clin Oncol       Date:  2014-02-12

9.  Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.

Authors:  Jing Zhou; Jacqueline Blundell; Shiori Ogawa; Chang-Hyuk Kwon; Wei Zhang; Christopher Sinton; Craig M Powell; Luis F Parada
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

Review 10.  PTEN hamartoma tumor syndromes.

Authors:  Gideon M Blumenthal; Phillip A Dennis
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.